1. Home
  2. OPRX vs TLSA Comparison

OPRX vs TLSA Comparison

Compare OPRX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$13.48

Market Cap

245.7M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.55

Market Cap

200.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
TLSA
Founded
2006
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
200.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
OPRX
TLSA
Price
$13.48
$1.55
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$14.83
N/A
AVG Volume (30 Days)
248.0K
456.5K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$109,506,000.00
N/A
Revenue This Year
$19.77
N/A
Revenue Next Year
$11.33
N/A
P/E Ratio
$7,406.92
N/A
Revenue Growth
24.18
N/A
52 Week Low
$3.99
$0.63
52 Week High
$22.25
$2.60

Technical Indicators

Market Signals
Indicator
OPRX
TLSA
Relative Strength Index (RSI) 39.23 41.48
Support Level $12.66 $1.39
Resistance Level $13.71 $1.60
Average True Range (ATR) 0.68 0.18
MACD 0.07 -0.02
Stochastic Oscillator 35.81 41.67

Price Performance

Historical Comparison
OPRX
TLSA

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: